Physician profile
Taylor Harmon
NPI 1396304184
$7,741.43
in general payments reported to CMS, 2019-2025
8 companies · $6,711 in 2025
The $6,711 reported for 2025 was more than what 87% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.17 · 2023: $352 · 2024: $658 · 2025: $6,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,889 · Food and Beverage: $3,547 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,889.37 |
| Food and Beverage | $3,547.41 |
| Education | $284.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,507.53 | 2025 | Indigo System, Ruby Coil, Penumbra System |
| Boston Scientific Corporation | $1,875.42 | 2023-2025 | Obsidio, General - Embolics, Embold Fibered |
| Imperative Care, INC | $330.61 | 2024-2025 | Zoom 88-T Large Distal Platform, Symphony Catheter |
| Medtronic, INC. | $306.56 | 2023 | Solitaire X, Hawkone |
| Stryker Corporation | $288.86 | 2023-2025 | Augment Injectable, Clottriever Bold Catheter, Omnicurve |
| Terumo Medical Corporation | $213.47 | 2025 | Navicross, Azur Cx Detachable |
| Angiodynamics, INC. | $198.81 | 2025 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $20.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.